Ads by Google

Lung Cancer

Bevacizumab Combined with Chemotherapy Prolongs Survival for Some Patients with Advanced Lung Cancer

Mar 15 2005 - 6:35am

Results from a clinical trial for patients with previously untreated advanced non squamous, non small cell lung cancer show that those patients who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.